Cargando…
PARP Inhibitors and Haematological Malignancies—Friend or Foe?
SIMPLE SUMMARY: PARP inhibitors are a class of orally active drugs that kill a range of cancer types by inducing synthetic lethality. The usefulness of PARP inhibitors for the treatment of haematological malignancies has begun to be explored in a variety of both pre-clinical models and human clinica...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582507/ https://www.ncbi.nlm.nih.gov/pubmed/34771492 http://dx.doi.org/10.3390/cancers13215328 |